US Patent Issued to Medicis Pharmaceutical, Virginia Commonwealth University, The United States Government as Represented by the Department of Veterans Affairs on June 2 for "Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes, and prediabetes" (Virginia, California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,805, issued on June 2, was assigned to Medicis Pharmaceutical Corp. (Bridgewater, N.J.), Virginia Commonwealth University (Richmond, Va.) and The United States Government as Represented by the Department of Veterans Affairs (Washington).

"Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes, and prediabetes" was invented by Shunlin Ren (Richmond, Va.), Yaping Wang (Richmond, Va.), WeiQi Lin (Emerald Hills, Calif.), James E. Brown (Los Gatos, Calif.) and Terrence Blaschke (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present disclosure include methods for treating at least o...